reference/6627059

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6627059

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	877
issn	1538-8514 1535-7163
issueIdentifier	6
pageRange	865-877
publicationName	Molecular Cancer Therapeutics
startingPage	865
bibliographicCitation	Min A, Im SA, Yoon YK, Song SH, Nam HJ, Hur HS, Kim HP, Lee KH, Han SW, Oh DY, Kim TY, O'Connor MJ, Kim WH, Bang YJ. RAD51C-deficient cancer cells are highly sensitive to the PARP inhibitor olaparib. Mol Cancer Ther. 2013 Jun;12(6):865–77. doi: 10.1158/1535-7163.mct-12-0950. PMID: 23512992.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dce68b61044e581129b4e52f14a01e6b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf634913fc681a881d5b20db6d1afdd5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_389576ad3e988a867bbb8cd2adddebdd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec1a8650dc5788ccfc940b121634ca2f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3f2cd76bcd147aa52c0447393dc8493 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_357d7ea0abd9000eadf95f76ffa584c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26d99f23c0e08234145208ef2e024ab6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65b4915fc977f76d2f9754caf41b7a00 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e2b1f3a219015fe879ec8efab38c097c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2153c88db5da839197449f42e2b3dee4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_316f49443d95905ff6e70ad9918957f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d920409f9430cd9a7e413b626949465e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d03875c0dcaa3e535e36f022212a3b02 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1785565e041293a1853aaf6fd467488f
date	2013-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1158/1535-7163.mct-12-0950 https://pubmed.ncbi.nlm.nih.gov/23512992
isPartOf	https://portal.issn.org/resource/ISSN/1538-8514 https://portal.issn.org/resource/ISSN/1535-7163 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib
discusses	http://id.nlm.nih.gov/mesh/M0016884 http://id.nlm.nih.gov/mesh/M0016766 http://id.nlm.nih.gov/mesh/M000601132 http://id.nlm.nih.gov/mesh/M0537510 http://id.nlm.nih.gov/mesh/M0018388 http://id.nlm.nih.gov/mesh/M0006678 http://id.nlm.nih.gov/mesh/M0416275
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D010879Q000008 http://id.nlm.nih.gov/mesh/D010793Q000008 http://id.nlm.nih.gov/mesh/D004268Q000235 http://id.nlm.nih.gov/mesh/D000067856 http://id.nlm.nih.gov/mesh/D013274Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D015972 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D011838Q000008 http://id.nlm.nih.gov/mesh/D013274Q000473 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D013274Q000235 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D058990 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D004268Q000172
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c093401b54d0d705d1bc7b045a24c672 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9305 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9091f9d0b2e1bc76ac280a84a8e3f42d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_467b750f9a6073f1098d1aa6270e135d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23725625 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5f8f19d61252fdce5cae1f415ad035b2

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5889

Total number of triples: 66.